Goldline Pharmaceutical
add_icon

Goldline Pharmaceutical

44.10
-1.93
(-4.19%)
Market Cap
42.35 Cr
PE Ratio
-
Volume
1,38,000.00
Day High - Low
46.46 - 43.73
52W High-Low
60.00 - 41.76
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
42.35 Cr
EPS
4.11
PE Ratio
-
PB Ratio
2.19
Book Value
21.00
EBITDA
5.80
Dividend Yield
0.00 %
Industry
-
Sector
-
Return on Equity
27.37
Debt to Equity
1.22
Forecast For
Actual

Company News

View All News
Caret
neutral
Goldline Pharmaceutical Limited will hold a board meeting on June 09, 2026, to consider audited financial results for the half-year and year ended March 31, 2026.
Growth Rate
Revenue Growth
19.07 %
Net Income Growth
55.56 %
Cash Flow Change
-20.55 %
ROE
19.21 %
ROCE
18.67 %
EBITDA Margin (Avg.)
13.86 %

Yearly Financial Results

Annual Financials
2023
2024
2025
TTM
Revenue
20
24
28
0
Expenses
18
19
22
0
EBITDA
2
4
6
0
Operating Profit %
11 %
18 %
21 %
0 %
Depreciation
0
0
0
0
Interest
2
2
2
0
Profit Before Tax
0
3
4
0
Tax
0
1
1
0
Net Profit
0
2
3
0
EPS in ₹
0.43
3.01
4.11
0.00

Balance Sheet

Balance Sheet
2023
2024
2025
Total Assets
19
23
26
Fixed Assets
3
3
3
Current Assets
17
20
23
Capital Work in Progress
0
0
0
Investments
0
0
0
Other Assets
17
20
23
Total Equity & Liabilities
19
23
26
Current Liabilities
9
10
12
Non Current Liabilities
5
5
4
Total Equity
6
8
10
Reserve & Surplus
2
4
2
Share Capital
4
4
9

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
-0
1
0
Investing Activities
-1
-1
0
Operating Activities
2
3
2
Financing Activities
-1
-1
-2

Share Holding

% Holding
Sept 2025
May 2026
Promoter
79.71 %
79.71 %
FIIs
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
Others
20.29 %
20.29 %
No of Share Holders
20
20

Technical Indicators

RSI(14)
Oversold
0.00
ATR(14)
Volatile
0.00
STOCH(9,6)
0.00
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
0.00
WillR(14)
Overbought
0.00